Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

PAST ISSUES
Volume 10
Number 4

Functional Genomics and Chromatin: Why understanding gene expression regulation is essential to revolutionize cancer therapy?
207-213
Novel Techniques in Radiation Therapy
214-216
Minimally invasive total mesorectal excision for extraperitoneal rectal cancer: Why patients should seek specialized hospitals and surgeons?
217-219
KRAS mutation testing: Why is it now not recommended for colorectal cancer EGFR inhibitors treatment decision?
220-222
Field-in-Field Technique as a Treatment of Choice in Tangential Whole Breast Irradiation
223-225
Assessing resistance to neoadjuvant treatment for breast cancer
226-228
Cytoreductive Surgery for Ovarian Cancer: Is Splenectomy indicated?
229-231
Peritoneal recurrence: The challenge in gastric cancer treatment and efforts to prevent
232-234
Total gastrectomy: Preventing hereditary diffuse gastric cancer
235-237
Breast cancer risk-reducing surgery and BRCA testing
238-240
Sigmoid or rectal cancer: do patients benefit from high ligation of inferior mesenteric artery?
241-243
HER2 status-based selection of gastric cancer patients for trastuzumab treatment.
244-246
How to prevent or treat hereditary diffuse gastric cancer?
247-249
Asymmetric open field-in-field can replace wedged fields in tangential whole breast irradiation
250-255
Translational advances and challenges for pharmacogenomics-based prescription of drugs
256-261

Online ISSN : 1109 - 7647
Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 9 September 2011